- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT04034914
Yoga Intervention in Supporting Children With Cancer and Their Parents During Chemotherapy Infusion
A Preliminary Pilot Study to Tailor and Evaluate the Feasibility of Child and Parent Yoga (CAPY) During Chemotherapy Infusion
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
PRIMARY OBJECTIVES:
- To determine the feasibility of Yoga for children with cancer and their parents, specifically
- Identify possible required modifications for safe and feasible practice during infusions.
- Obtain recruitment estimates and determine barriers.
- Assess satisfaction.
SECONDARY OBJECTIVES:
- To determine the feasibility of administering and acceptability of measures to assess preliminary efficacy of Yoga for the following outcomes:
- Child psychological distress (stress, anxiety).
- Parent psychological distress (stress, anxiety, anger, depression).
- Child and parent physiological stress (heart rate, respiratory rate, and blood pressure).
- Parent-child communication.
- Child physical symptoms.
OUTLINE:
Patients and parents participate in up to 8 Yoga sessions consisting of check in, awareness, breathing practices, gentle movement, and relaxation over 30 minutes each.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Tennessee
-
Nashville, Tennessee, États-Unis, 37232
- Vanderbilt University School of Nursing
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Children: 8-17 years of age, within 4 weeks of: 1) any new cancer diagnosis or newly diagnosed relapsed cancer, and 2) medical clearance who anticipate 3-weeks of continous contact with Monroe Carell Jr. Children's Hospital.
- Parents: 18 years of age and older, child's primary caregiver (planning to attend appointments, infusions visits, or be in hospital rooms/clinics) or secondary caregiver (an as needed back-up to primary).
Children and Parents: able to speak and understand English, absence of cognitive impairment, and willing to engage in Yoga as part of a dyad.
Exclusion Criteria:
- CHILDREN: Medical conditions that would prohibit the safe implementation of a Yoga practice
- PARENTS: Practices Yoga weekly
- PARENTS: Pregnant or plans to become pregnant during next 3 months
- CHILDREN AND PARENTS: Unwilling to work as a dyad.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Thérapie de yoga
|
Etudes annexes
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Modifications
Délai: Up to 2 years
|
Will be assessed qualitatively.
A tally of the specific modifications will be maintained to determine if particular modification are made more frequently than others.
|
Up to 2 years
|
|
Recruitment
Délai: Up to 2 years
|
The total number of eligible child-parent dyads approached to achieve an enrolled sample of 5 dyads will be tallied.
|
Up to 2 years
|
|
Retention
Délai: Up to 2 years
|
The number of the enrolled child-parent dyads who complete both the self-report assessments required at baseline (T1 - prior to first Yoga session), the Yoga protocol, and the measures at the end-of-infusion (T2 - prior to last Yoga session) will be tallied.
The proportion completing will be used to inform the level of over-recruitment required in future studies of efficacy.
|
Up to 2 years
|
|
Barriers
Délai: Up to 2 years
|
Participants who do not complete the study will be contacted and queried as to the reason for the lack of completion.
A tally of the specific barriers will be maintained to determine if particular barriers are encountered more frequently than others.
This information will inform possible modifications required to the protocol in future research.
|
Up to 2 years
|
|
Participant satisfaction
Délai: Up to 2 years
|
The total number of responses to the 14 satisfaction questions with a rating > 4 (maximum rating = 7) will be generated for each of the 5 parent participants.
It is expected that all participants will exceed that threshold for all questions.
If not, frequency distributions will be used to summarize the responses to each of the 14 items to assess which produced the lower ratings.
Responses to open-ended questions will be analyzed qualitatively.
Findings from both components of the satisfaction survey (program satisfaction and yoga survey) will be used to revise the Yoga protocol as needed.
|
Up to 2 years
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Child psychological distress
Délai: Up to 2 years
|
Will assess child distress using Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Psychological Stress Experiences- Short Form
|
Up to 2 years
|
|
Parent psychological distress
Délai: Up to 2 years
|
Will assess parent distress using the PROMIS Depression - Short Form
|
Up to 2 years
|
|
Parent psychological distress
Délai: Up to 2 years
|
Will assess parent distress using the PROMIS Emotional Distress - Anger - Short Form
|
Up to 2 years
|
|
Parent psychological distress
Délai: Up to 2 years
|
Will assess parent distress using the PROMIS Anxiety
|
Up to 2 years
|
|
Child and parent physiological stress
Délai: Up to 2 years
|
Will assess blood pressure
|
Up to 2 years
|
|
Child and parent physiological stress
Délai: Up to 2 years
|
Will assess heart rate
|
Up to 2 years
|
|
Child and parent physiological stress
Délai: Up to 2 years
|
Will assess respiratory rate
|
Up to 2 years
|
|
Parent-child communication
Délai: Up to 2 years
|
Will be assessed using the Parent-Adolescent Communication Scale (PACS).
Participants answer 20-40 questions.
A total score is calculated ranging from 20-100 with higher scores indicating more positive communication.
|
Up to 2 years
|
|
Child physical symptoms
Délai: Up to 2 years
|
Will be assessed using the PROMIS Pediatric Physical Stress Experiences -Short Form.
|
Up to 2 years
|
|
Parent psychological distress
Délai: Up to 2 years
|
Parent distress will be assessed using the NIH Toolbox Perceived Stress
|
Up to 2 years
|
|
Child psychological distress
Délai: Up to 2 years
|
Child distress will be assessed using the PROMIS Pediatric Anxiety - Short Form
|
Up to 2 years
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Terrah Akard, PhD, Vanderbilt University School of Nursing
- Chercheur principal: Sheila Ridner, PhD, Vanderbilt University School of Nursing
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- VICC SUPP 1935
- NCI-2019-04525 (Identificateur de registre: NCI, Clinical Trials Reporting Program)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .